The impact of PI3K/AKT inhibitor on the radiosensitization of breast cancer cells

被引:0
|
作者
Fu, S
Zeng, QW
Sun, Y
Zhang, Q
Shao, YH
Jian, GL
机构
[1] Jiao Tong Univ, Shanghai Hosp 6, Shanghai 200233, Peoples R China
[2] Fudan Univ, Shanghai Canc Hosp, Shanghai 200032, Peoples R China
关键词
breast cancer; Ly294002; PI3K; AKT; radiotherapy;
D O I
10.1016/S0167-8140(06)80740-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
263
引用
收藏
页码:S93 / S93
页数:1
相关论文
共 50 条
  • [31] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    Woo, S-U
    Sangai, T.
    Akcakanat, A.
    Chen, H.
    Wei, C.
    Meric-Bernstam, F.
    [J]. ONCOGENESIS, 2017, 6 : e385 - e385
  • [32] HS-173, a novel PI3K inhibitor enhances radiosensitivity of breast cancer cells
    Lee, H.
    Park, J. H.
    Jung, K. H.
    Lim, J. H.
    Hong, S-S
    [J]. INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2022, 20 (02): : 347 - 352
  • [33] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    S-U Woo
    T Sangai
    A Akcakanat
    H Chen
    C Wei
    F Meric-Bernstam
    [J]. Oncogenesis, 2017, 6 : e385 - e385
  • [34] Incidence of oncogenes in PI3K/AKT and MAPK signaling pathways in breast cancer
    Cejalvo, J. M.
    Perez Fidalgo, J. A.
    Bermejo, B.
    Ibarrola-Villaba, M.
    Burgues, O.
    Ribas, G.
    Martinez, M. T.
    Lluch-Hernandez, A.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [35] Involvement of PI3K/Akt pathway alterations in breast cancer treated with trastuzumab
    Fernandez Garcia, M.
    Centeno Ramos, I.
    Suarez Fernandez, L.
    Fuentes, N.
    Vivanco Allende, B.
    Garcia Pravia, C.
    Balbin Felechosa, M.
    Fresno Forcelledo, M. F.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S240 - S241
  • [36] The PI3K/AKT/mTOR signaling pathway: Implications in the treatment of breast cancer
    Andreopoulou E.
    [J]. Current Breast Cancer Reports, 2011, 3 (1) : 63 - 74
  • [37] Clinical development of PI3K/AKT pathway inhibitors in breast cancer.
    Derynck, Mika
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 22 - 22
  • [38] Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
    Khatpe, Aditi S.
    Adebayo, Adedeji K.
    Herodotou, Christopher A.
    Kumar, Brijesh
    Nakshatri, Harikrishna
    [J]. CANCERS, 2021, 13 (03) : 1 - 20
  • [39] Activation of PI3K/Akt signaling and hormone resistance in breast cancer.
    Tokunaga E.
    Kimura Y.
    Mashino K.
    Oki E.
    Kataoka A.
    Ohno S.
    Morita M.
    Kakeji Y.
    Baba H.
    Maehara Y.
    [J]. Breast Cancer, 2006, 13 (2) : 137 - 144
  • [40] Targeting PI3K/AKT pathway in triple-negative breast cancer
    Delaloge, Suzette
    DeForceville, Louise
    [J]. LANCET ONCOLOGY, 2017, 18 (10): : 1293 - 1294